Recall Register

Drug recall: Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label…

Class III FDA enforcement event 64533. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Novartis Consumer Health started this drug recall on 7 Mar 2013. The firm address in the FDA record is in Lincoln, NE. FDA put the recall in Class III. FDA event 64533 has 5 product records. The first FDA enforcement report date is 27 Mar 2013. The record gives the status Terminated, with the termination date 26 Nov 2014.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide and Panama

Recalling firm

Novartis Consumer Health, Lincoln, NE.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

5 product records in the event.

FDA event 64533: product records
Recall numberProductQuantityClassStatusReport date
D-207-2013Myoflex (trolamine salicylate) 10%, Pain Relieving Cream, a) 2-oz tube, b) 4-oz. tube, OTC. The firm name on the label is Novartis Consumer Health, Inc., Parsippany, NJ 07054.240,120/2-oz. tubes and 429,144/4-oz. tubesClass IIITerminated27 Mar 2013
D-208-2013Nupercainal, Dibucaine, Hemorrhoidal & Topical Analgesic Ointment, a) 1-oz. tubes (NDC 0067-5812-96), b) 2-oz. tubes (NDC 0067-5812-86), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.91,872/1-oz. tubes and 94,464/2-oz. tubesClass IIITerminated27 Mar 2013
D-209-20134 way Nasal Decongestant Fast Acting Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2086-05), b) 1-fl. oz. bottles (NDC 0067-2086-01), c) 1.25-fl. oz. bottles (NDC 0067-2086-15), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.538,092/.5-fl. oz. bottles, 1,186,740/1-oz. bottles, and 138,528/1.25-fl. oz bottlesClass IIITerminated27 Mar 2013
D-210-20134 way Nasal Decongestant Menthol Nasal Spray, containing phenylephrine hydrochloride 1%, a) 1/2-fl. oz. bottles (NDC 0067-2087-05) b) 1-fl. oz. bottles (NDC 0067-2087-01), OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.44,604/ .5-fl. oz. bottles and 439,452 /1-fl. oz. bottlesClass IIITerminated27 Mar 2013
D-211-20134 way Saline Moisturizing Mist with Eucalyptol & Menthol, 1-fl. oz. bottles, OTC. Distributed by Novartis Consumer Health, Inc., Parsippany, NJ 07054.227,124 bottlesClass IIITerminated27 Mar 2013

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2013
370
Share of these events in Class III
26%
Product records in this event
5Median of the firm: 5
Events of the firm on the register
11

Other events of the firm

Other FDA enforcement events of Novartis Consumer Health
InitiatedProduct (first record)TypeClassRecords
18 Dec 2013Benefiber fiber supplement stick packs, sugar free and taste free, packaged in the following configurations: (1) BenefibFoodClass II1
3 Sep 2013Loratadine, USP 10 mg, Antihistamine, packaged in blister packs. All manufactured by Novartis Consumer Health, Inc, LincDrugClass III1
6 Aug 2013Maalox Extra Strength Antacid with Anti-Gas (calcium carbonate and simethicone) chewable tablets, 1000 mg/60 mg, AssorteDrugClass III9
6 Aug 2013Benefiber, Fiber plus Calcium Supplement, Wild Berry Chewables 90ct, sugar free, chewable tablets bottle. Novartis ConsuFoodClass III5
18 Jun 2013Theraflu Flu & Sore Throat (acetaminophen 650 mg, pheniramine maleate 20 mg, phenylephrine hydrochloride 10 mg) powder pDrugClass II16
6 Jun 2013Excedrin Extra Strength (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-ct tablets in pouches b)DrugClass II4
15 May 2013Maximum Strength Comtrex Day/Night Cold & Cough, Acetaminophen 325mg, Chlorpheniramine Maleate 2mg, Dextromethorphan HBRDrugClass III7
7 May 2013Benefiber Fiber Supplement, Orange Natural Flavor, Non-Thickening Powder, Sugar Free, packaged in 5.7-oz. (35 servings) FoodClass II6
19 Apr 2013Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJDrugClass III1
19 Feb 2013Novartis Lamisil AT Cream, Terbinafine Hydrochloride Cream 1% Antifungal, Novartis Consumer Health, Inc., Parsippany, NJDrugClass III5

Novartis Consumer Health: all 11 events

Official channels

Cite this page

Recall Register. FDA enforcement event 64533. https://recallregister.com/fda/iii/64533/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide and Panama
What quantity of product is in FDA event 64533?
The event has 5 product records. The first record gives this quantity: 240,120/2-oz. tubes and 429,144/4-oz. tubes
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2013 have the same class?
26% of the 370 drug events that started in 2013 are in Class III.